News

Feds recommend pausing vaccine for mosquito-borne disease chikungunya in people over 60
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
After 2 reported deaths, officials tell Ixchiq users age 60+ to stop vaccine temporarily
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...
Becker's Hospital Review4h
FDA, CDC: Pause chikungunya shots in older adults
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...
Avoid Chikungunya Vaccine If You're Over 60, Say US Health Officials; Here Are The Details
Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...
US health officials advise older travelers not to get a chikungunya vaccine
The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...
Medscape12h
Suspend Use of Chikungunya Vaccine in Adults Aged 60+, Agencies Advise
The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.
2VALN : US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For...
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...